Alzheimer's disease, a progressive neurodegenerative disorder, poses a significant global health challenge. It primarily affects older adults, with the risk increasing with age. Globally, an estimated 50 million people were living with dementia in 2021, with Alzheimer's disease comprising 60-70% of cases. This prevalence is expected to rise as populations age, potentially reaching 152 million by 2050. Geographically, prevalence rates vary, with higher incidences observed in developed regions due to longer life expectancies and improved diagnostic capabilities. In the United States alone, over 6 million people aged 65 and older are living with Alzheimer's. Understanding these epidemiological trends is crucial for healthcare planning, resource allocation, and advancing research efforts aimed at prevention and treatment.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia